Features of Pathogenesis of Human Viral Infections and Antiviral Drugs
Among infectious diseases, viral infections are the leading cause of death worldwide, especially in the most low-income countries, particularly in young children. Most of the human viruses are all well characterized in terms of structure, life-cycle, tropism, and associated primary pathologies, but...
Saved in:
| Sonstige: | |
|---|---|
| Year of Publication: | 2021 |
| Language: | English |
| Physical Description: | 1 electronic resource (84 p.) |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| id |
993545155204498 |
|---|---|
| ctrlnum |
(CKB)5400000000040695 (oapen)https://directory.doabooks.org/handle/20.500.12854/68341 (EXLCZ)995400000000040695 |
| collection |
bib_alma |
| record_format |
marc |
| spelling |
Aquaro, Stefano edt Features of Pathogenesis of Human Viral Infections and Antiviral Drugs Basel, Switzerland MDPI - Multidisciplinary Digital Publishing Institute 2021 1 electronic resource (84 p.) text txt rdacontent computer c rdamedia online resource cr rdacarrier Among infectious diseases, viral infections are the leading cause of death worldwide, especially in the most low-income countries, particularly in young children. Most of the human viruses are all well characterized in terms of structure, life-cycle, tropism, and associated primary pathologies, but many of the pathogenetic mechanisms underlying their ability to cause acute infection, persist or reactivate in the host and cause chronic and/or degenerative damage, and still need to be fully clarified. At the same time, it seems necessary to develop novel therapeutic approaches and rationale, and possibly more potent antiviral compounds that are addressed to novel targets. English Medicine bicssc hRSV F gene G gene children respiratory diseases genotyping Saudi Arabia α chemokine receptor 4 β-chemokine receptor 5 human immunodeficiency virus monocyte-derived macrophages HPV sexually transmitted diseases (STDs) laboratory methods PCR genotypes surveillance epidemiology exopolysaccharides lactic acid bacteria human adenovirus type 5 antiviral activity cell cycle prevalence hepatitis B virus genotype bahrain sRAGE oxidative stress inflammation warts 3-03943-917-0 3-03943-918-9 Aquaro, Stefano oth |
| language |
English |
| format |
eBook |
| author2 |
Aquaro, Stefano |
| author_facet |
Aquaro, Stefano |
| author2_variant |
s a sa |
| author2_role |
Sonstige |
| title |
Features of Pathogenesis of Human Viral Infections and Antiviral Drugs |
| spellingShingle |
Features of Pathogenesis of Human Viral Infections and Antiviral Drugs |
| title_full |
Features of Pathogenesis of Human Viral Infections and Antiviral Drugs |
| title_fullStr |
Features of Pathogenesis of Human Viral Infections and Antiviral Drugs |
| title_full_unstemmed |
Features of Pathogenesis of Human Viral Infections and Antiviral Drugs |
| title_auth |
Features of Pathogenesis of Human Viral Infections and Antiviral Drugs |
| title_new |
Features of Pathogenesis of Human Viral Infections and Antiviral Drugs |
| title_sort |
features of pathogenesis of human viral infections and antiviral drugs |
| publisher |
MDPI - Multidisciplinary Digital Publishing Institute |
| publishDate |
2021 |
| physical |
1 electronic resource (84 p.) |
| isbn |
3-03943-917-0 3-03943-918-9 |
| illustrated |
Not Illustrated |
| work_keys_str_mv |
AT aquarostefano featuresofpathogenesisofhumanviralinfectionsandantiviraldrugs |
| status_str |
n |
| ids_txt_mv |
(CKB)5400000000040695 (oapen)https://directory.doabooks.org/handle/20.500.12854/68341 (EXLCZ)995400000000040695 |
| carrierType_str_mv |
cr |
| is_hierarchy_title |
Features of Pathogenesis of Human Viral Infections and Antiviral Drugs |
| author2_original_writing_str_mv |
noLinkedField |
| _version_ |
1787548485139038209 |
| fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02564nam-a2200661z--4500</leader><controlfield tag="001">993545155204498</controlfield><controlfield tag="005">20231214133417.0</controlfield><controlfield tag="006">m o d </controlfield><controlfield tag="007">cr|mn|---annan</controlfield><controlfield tag="008">202105s2021 xx |||||o ||| 0|eng d</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(CKB)5400000000040695</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(oapen)https://directory.doabooks.org/handle/20.500.12854/68341</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(EXLCZ)995400000000040695</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Aquaro, Stefano</subfield><subfield code="4">edt</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Features of Pathogenesis of Human Viral Infections and Antiviral Drugs</subfield></datafield><datafield tag="260" ind1=" " ind2=" "><subfield code="a">Basel, Switzerland</subfield><subfield code="b">MDPI - Multidisciplinary Digital Publishing Institute</subfield><subfield code="c">2021</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 electronic resource (84 p.)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">computer</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">online resource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Among infectious diseases, viral infections are the leading cause of death worldwide, especially in the most low-income countries, particularly in young children. Most of the human viruses are all well characterized in terms of structure, life-cycle, tropism, and associated primary pathologies, but many of the pathogenetic mechanisms underlying their ability to cause acute infection, persist or reactivate in the host and cause chronic and/or degenerative damage, and still need to be fully clarified. At the same time, it seems necessary to develop novel therapeutic approaches and rationale, and possibly more potent antiviral compounds that are addressed to novel targets.</subfield></datafield><datafield tag="546" ind1=" " ind2=" "><subfield code="a">English</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Medicine</subfield><subfield code="2">bicssc</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">hRSV</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">F gene</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">G gene</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">children</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">respiratory diseases</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">genotyping</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Saudi Arabia</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">α chemokine receptor 4</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">β-chemokine receptor 5</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">human immunodeficiency virus</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">monocyte-derived macrophages</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">HPV</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">sexually transmitted diseases (STDs)</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">laboratory methods</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">PCR</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">genotypes</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">surveillance</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">epidemiology</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">exopolysaccharides</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">lactic acid bacteria</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">human adenovirus type 5</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">antiviral activity</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">cell cycle</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">prevalence</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">hepatitis B virus</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">genotype</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">bahrain</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">sRAGE</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">oxidative stress</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">inflammation</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">warts</subfield></datafield><datafield tag="776" ind1=" " ind2=" "><subfield code="z">3-03943-917-0</subfield></datafield><datafield tag="776" ind1=" " ind2=" "><subfield code="z">3-03943-918-9</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Aquaro, Stefano</subfield><subfield code="4">oth</subfield></datafield><datafield tag="906" ind1=" " ind2=" "><subfield code="a">BOOK</subfield></datafield><datafield tag="ADM" ind1=" " ind2=" "><subfield code="b">2023-12-15 05:53:16 Europe/Vienna</subfield><subfield code="f">system</subfield><subfield code="c">marc21</subfield><subfield code="a">2022-04-04 09:22:53 Europe/Vienna</subfield><subfield code="g">false</subfield></datafield><datafield tag="AVE" ind1=" " ind2=" "><subfield code="i">DOAB Directory of Open Access Books</subfield><subfield code="P">DOAB Directory of Open Access Books</subfield><subfield code="x">https://eu02.alma.exlibrisgroup.com/view/uresolver/43ACC_OEAW/openurl?u.ignore_date_coverage=true&portfolio_pid=5337869100004498&Force_direct=true</subfield><subfield code="Z">5337869100004498</subfield><subfield code="b">Available</subfield><subfield code="8">5337869100004498</subfield></datafield></record></collection> |